Beggs Rachel E, Kelly Michael E, Eltayeb Omer, Crotty Paul, McDermott Ray, Ridgway Paul F
Department of Surgery, The Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital, Dublin, Ireland.
JOP. 2012 Sep 10;13(5):470-5. doi: 10.6092/1590-8577/821.
Large cell neuroendocrine carcinomas of the ampulla of Vater are rare and confer a very poor prognosis despite aggressive therapy. There are few case reports of large cell neuroendocrine carcinomas of the ampulla of Vater in the literature and to date no studies have been done to establish optimal management. We describe a pooled case series from published reports of neuroendocrine carcinomas of the ampulla of Vater including a case which presented to our institution.
A narrative review was undertaken including all published English case reports of large cell neuroendocrine carcinomas of the ampulla of Vater. Our primary outcome was to determine the overall survival.
Twenty cases of large cell neuroendocrine carcinomas of the ampulla of Vater were identified. Seventy-six percent of patients were reported to have died of disease with a mean survival of 11.8 months. Twenty percent of the tumours were associated with an adenoma. The approximate median survivals were 15 months for those with an associated adenoma and 11 months without.
This pooled analysis demonstrates both the rarity and poor prognosis of large cell neuroendocrine carcinomas of the ampulla of Vater. Although surgical resection is the mainstay of treatment, we review common adjuvant chemotherapy regimes. Prognosis may be improved when these tumours are associated with adenomas, however, further studies are needed.
壶腹大细胞神经内分泌癌罕见,尽管积极治疗,预后仍很差。文献中壶腹大细胞神经内分泌癌的病例报告很少,迄今为止尚未开展研究以确定最佳治疗方案。我们描述了一个来自已发表的壶腹神经内分泌癌报告的汇总病例系列,包括我院收治的1例。
进行叙述性综述,纳入所有已发表的壶腹大细胞神经内分泌癌英文病例报告。我们的主要结局是确定总生存期。
共识别出20例壶腹大细胞神经内分泌癌。据报告,76%的患者死于该病,平均生存期为11.8个月。20%的肿瘤与腺瘤相关。伴有腺瘤者的中位生存期约为15个月,无腺瘤者为11个月。
这项汇总分析表明壶腹大细胞神经内分泌癌既罕见且预后不良。虽然手术切除是主要治疗方法,但我们回顾了常用的辅助化疗方案。当这些肿瘤与腺瘤相关时,预后可能改善,然而,仍需进一步研究。